Table 3.
Compound | PC3 IC50 (µM) | LNCaP IC50 (µM) |
---|---|---|
Bazedoxifene | 7.5 ± 0.3 | 11.1 ± 0.6 * |
LS-TG-2P | 6.2 ± 0.2 * | 7.7 ± 0.3 |
LS-TF-3P | 19.0 ± 0.8 | 50.0 ± 2.9 |
* 95% confidence interval was ambiguous due to a steep dose–response curve. IC50 ± SE.
Compound | PC3 IC50 (µM) | LNCaP IC50 (µM) |
---|---|---|
Bazedoxifene | 7.5 ± 0.3 | 11.1 ± 0.6 * |
LS-TG-2P | 6.2 ± 0.2 * | 7.7 ± 0.3 |
LS-TF-3P | 19.0 ± 0.8 | 50.0 ± 2.9 |
* 95% confidence interval was ambiguous due to a steep dose–response curve. IC50 ± SE.